Director Noah News Today

SARANAC LAKE — The Northern Forest Canoe Trail has completed restoration of the historic Indian Carry portage connecting Stony Creek Ponds and Upper Saranac

LYNDON — The Northern Forest Canoe Trail (NFCT), in partnership with the town of Lyndon and with support from the Upper Connecticut River Mitigation and Enhancement Fund, has completed two

Several projects along the Saranac River section of the Northern Forest Canoe Trail (NFCT) will impact access for paddlers and other users this fall. The pro

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $9.67 and traded as high as $12.66. Merrimack Pharmaceuticals shares last traded at $12.51, with a volume of 63,141 shares trading hands. Analysts […]

The lineup for the 2022 edition of Fantastic Fest will include Smile, The Menu, V/H/S/99, Bones & All, FleshEater, and much more.

Equities researchers at StockNews.com started coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Merrimack Pharmaceuticals Stock Performance Shares of MACK stock opened at $5.09 on Monday. Merrimack Pharmaceuticals has a fifty-two […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $5.46 and traded as high as $5.89. Merrimack Pharmaceuticals shares last traded at $5.68, with a volume of 7,552 shares. Separately, StockNews.com started coverage on Merrimack Pharmaceuticals […]

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating) Director Noah G. Levy bought 20,938 shares of the company’s stock in a transaction dated Tuesday, June 14th. The stock was purchased at an average cost of $5.17 per share, for a total transaction of $108,249.46. Following the completion of the acquisition, the director now owns 1,010,515 shares […]

StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK opened at $5.58 on Wednesday. The stock’s 50-day moving average is $6.24 and its two-hundred day moving average is $5.15. The stock has […]